HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.

Abstract
Primaquine-induced hemolytic anemia is a toxic side effect that is due to premature splenic sequestration of intact erythrocytes. Previous studies have suggested that a phenolic metabolite, 5-hydroxyprimaquine (5-HPQ), mediates primaquine hemotoxicity by generating reactive oxygen species (ROS) within erythrocytes that overwhelm antioxidant defenses. However, the nature of the oxidative stress is not understood, and the molecular targets, whether protein and/or lipid, are unknown. To investigate the mechanism underlying the hemolytic activity of 5-HPQ, we have examined the effect of hemolytic concentrations of 5-HPQ on ROS formation within rat erythrocytes using the cellular ROS probe, 2',7'-dichlorodihydrofluoresein diacetate. In addition, we examined the effect of 5-HPQ on membrane lipids and cytoskeletal proteins. The data indicate that 5-HPQ causes a prolonged, concentration-dependent generation of ROS within erythrocytes. Interestingly, 5-HPQ-generated ROS was not associated with the onset of lipid peroxidation or an alteration in phosphatidylserine asymmetry. Instead, 5-HPQ induced oxidative injury to the erythrocyte cytoskeleton, as evidenced by changes in the normal electrophoretic pattern of membrane ghost proteins. Immunoblotting with an anti-hemoglobin antibody revealed that these changes were due primarily to the formation of disulfide-linked hemoglobin-skeletal protein adducts. The data suggest that cytoskeletal protein damage, rather than membrane lipid peroxidation or loss of phosphatidylserine asymmetry, underlies the process of removal of erythrocytes exposed to 5-HPQ.
AuthorsZachary S Bowman, Jason D Morrow, David J Jollow, David C McMillan
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 314 Issue 2 Pg. 838-45 (Aug 2005) ISSN: 0022-3565 [Print] United States
PMID15840764 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antimalarials
  • Cytoskeletal Proteins
  • Enzyme Inhibitors
  • Ionophores
  • Lipid Bilayers
  • Phosphatidylserines
  • Reactive Oxygen Species
  • 5-hydroxyprimaquine
  • Primaquine
  • Ethylmaleimide
  • Calcium
  • Dithiothreitol
Topics
  • Anemia, Hemolytic (chemically induced)
  • Animals
  • Antimalarials (toxicity)
  • Calcium (pharmacology)
  • Cell Membrane (drug effects, metabolism)
  • Cytoskeletal Proteins (metabolism)
  • Dithiothreitol (pharmacology)
  • Electrophoresis, Polyacrylamide Gel
  • Enzyme Inhibitors (pharmacology)
  • Erythrocyte Membrane (drug effects, metabolism)
  • Erythrocytes (metabolism)
  • Ethylmaleimide (pharmacology)
  • In Vitro Techniques
  • Ionophores (pharmacology)
  • Lipid Bilayers
  • Lipid Peroxidation (drug effects)
  • Male
  • Phosphatidylserines (blood)
  • Primaquine (analogs & derivatives, toxicity)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (blood)
  • Spleen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: